Therapeutic vaccination in patients with chronic hepatitis C genotype 1 using four courses of 8 + 6 + 6 + 6 intramuscular injections of 50 µg E1y at 3 week intervals: a multicenter, 3:1 randomized, double-blind, placebo-controlled, parallel-group study over 157 weeks in 122 patients
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2009
At a glance
- Drugs Hepatitis C vaccine (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Innogenetics
- 16 Sep 2009 Last checked against ISRCTN record.
- 10 Sep 2007 Interim results have been reported - for tolerability and for the primary endpoint.
- 19 Aug 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History